Latest news with #HyphaLabs
Yahoo
10-06-2025
- Business
- Yahoo
Hypha Labs Files New Patent Application for Its Suite of Artificial Intelligence (AI) Techniques for Its Mushroom Accelerator
LAS VEGAS, NV / / June 10, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), an Artificial Intelligence (AI) powered pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce the filing of a new patent application with the United States Patent and Trade Office (USPTO) for its current suite of Artificial Intelligence (AI) powered techniques to create functional mushroom ingredients in its Mushroom Accelerator. Hypha Labs' next-generation Mushroom Accelerator harnesses Artificial Intelligence and robust cloud connectivity to redefine how medicinal mushroom mycelium is cultivated. Each accelerator is wirelessly linked to a powerful cloud platform that analyzes real-time sensor data-covering temperature, oxygen, nutrient levels, and more-alongside a constantly growing database of successful harvests. The AI learning model uses these insights to automatically optimize every batch, providing users with real-time recommendations and precision control via an intuitive mobile app, accessible from anywhere. This means even home growers benefit from the collective learning of a global cultivation network, ensuring consistent, high-quality results with every cycle. What truly sets this system apart is its built-in over-the-air (OTA) update feature, which enables Hypha Labs to deliver ongoing software improvements and new AI capabilities directly to each bioreactor's onboard processor."It is a watershed moment for the Company that we have now arrived at a stage in our development that we are looking to fully protect our innovation and design as we inch closer to a product roll-out that truly personalizes and provides access to the magic of the mushroom to a potential market of millions of consumers," stated Stone Douglass, CEO, Hypha Labs. "We are most pleased to use the incredible and evolving power of Artificial Intelligence to refine one of nature's oldest and most revered ingredients… the mushroom." About Hypha Labs, Inc. The company has developed revolutionary, cutting-edge technology focused on new methods of producing the active ingredients found in a wide array of functional mushrooms using its patent-pending mushroom accelerators. The Company is positioning itself to play an important role in the burgeoning Functional Mushroom industry in addition to being a disruptive force in future and emerging mushroom opportunities. Visit us at SAFE HARBOR FORWARD LOOKING STATEMENTS: Ther Company wishes to remind the market that it is still engaged in an awareness program with Emerging Markets LLC as previously announced. This press release may contain forward looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise. From time to time, the Company may post new and material information on its website or through its social media profiles at the links below: LN: Twitter: For more information about Hypha Labs visit For the Company's current Investor Presentation please visit Investor and Media Relations: Integrity MediaInc.(888) 216-3595team@ SOURCE: Hypha Labs, Inc. View the original press release on ACCESS Newswire Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Associated Press
13-05-2025
- Business
- Associated Press
Hypha Labs Files Multiple Additional Patents for its Ground Breaking Mushroom Accelerator
LAS VEGAS, NV / ACCESS Newswire / May 13, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce the filing of additional patents with the United States Patent and Trade Office (USPTO) which it believes further protects the Company's innovations in the commercialization of a broad array of functional mushroom ingredients for the rapidly growing consumer and enterprise markets. The three additional patents that have been filed are as follows: 'We are blazing an innovative trail, harnessing the magic of the mushroom and bringing it everywhere from the comfort of the home to commercial kitchens who want predictable, scalable mushroom ingredients in their offering,' stated Stone Douglass, CEO, Hypha Labs. 'These patents, which we have briefly detailed herein, affirm our strong position in the space as we look to our product roll-out on the not-so-far horizon, protecting our mass production plans, A.I. integrations, and maybe most importantly our Replaceable Sterile Cartridge System which to the keen eye should make clear our evergreen relationship with the customer vis-à-vis the razor/razor blade model fully in play.' Hypha Labs remains committed to advancing the science of mushroom cultivation equipment and genetic research to accommodate these advances. The integration of its new HPLC machine and the variable loop autosampler upgrade marks a significant milestone in Hypha's journey to deliver innovative solutions and insights to our customers, clients and partners. About Hypha Labs, Inc. The company has developed revolutionary, cutting-edge technology focused on new methods of producing the active ingredients found in a wide array of functional mushrooms using its patent-pending mushroom accelerators. The Company is positioning itself to play an important role in the burgeoning Functional Mushroom industry in addition to being a disruptive force in future and emerging mushroom opportunities. Visit us at SAFE HARBOR FORWARD LOOKING STATEMENTS: This press release may contain forward looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as 'estimate,' 'project,' 'predict,' 'will,' 'would,' 'should,' 'could,' 'may,' 'might,' 'anticipate,' 'plan,' 'intend,' 'believe,' 'expect,' 'aim,' 'goal,' 'target,' 'objective,' 'likely' or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise. From time to time, the Company may post new and material information on its website or through its social media profiles at the links below: LN: FB: IG: Twitter: For more information about Hypha Labs visit For the Company's current Investor Presentation please visit Investor and Media Relations: Integrity MediaInc. (888) 216-3595 [email protected] SOURCE: Hypha Labs, Inc. press release
Yahoo
12-05-2025
- Business
- Yahoo
Emerging Markets Report: A Milestone for Mycelium
Underreported D.E.A. Letter and Policy Position Could be a Game Changer for Mushroom Enthusiasts An Emerging Markets Sponsored Commentary ORLANDO, Fla., May 12, 2025 (GLOBE NEWSWIRE) -- At the Emerging Market Report we are comprised of a team of veteran journalists, authors, former stock brokers, financial professionals, and unabashed opportunists who all come together to publish these tidy missives on our client profiles. We are constantly searching for impactful news that could be gamechangers for the Companies we cover. And we sure missed a big did just about everybody else. That big piece could be a major catalyst for Hypha Labs (OTCQB: FUNI) which makes the first at-home and commercial patent-pending mushroom ingredient maker of its kind. The elevator pitch is that Hypha Labs is to mushrooms as the clever Keurig was, is, to coffee. Massive potential disruptor in a massive market. Hypha's story is already a game changer as it is going to allow the soccer mom at home to make her preferred mushroom ingredient in a simple eight-day cycle. Pop in a cartridge, scan the bar code, wait eight days and enjoy the magic of the privacy, no more growing 'shrooms in animal feces. But the mushroom industry is a decade or more behind the Emancipation of Cannabis. That cannabis revolution has almost completely come already with weed available most everywhere and a reasonable expectation that the government will change the arcane way it is classified/scheduled at the federal cannabis movement started simply enough; some vocal folk argued the medicinal benefits AND the economic benefits to states that would listen and states started to go green. Once a few states implemented pro-Cannabis legislation they provided good working test market examples for other states to see that there wasn't a new filming of Reefer Madness on the streets and there were indeed many a cannabis driven dollar going into the state coffers that could be used for things like better schools and roads. I've buried the lead here but then again, it's been buried for a long, long time. Don't kill the the buried bombshell: The Drug Enforcement Agency (DEA) appears to have taken a firm position that mycelium is ok to ship across state lines, although there are three states which currently don't allow mycelium to be shipped across state lines. Mycelium is the inactive root-like structure which later becomes a mushroom when it begins to fruit, which is what happens when it is fed nutrients. That's pretty good news if you're a company like Hypha Labs that will ship mycelium across eligible state lines once the retail roll-out of the Micropearls machine goes live. As described, Hypha sends you mycelium and based on your desires and a little A.I. you set your eight day harvest to whatever mushroom crop you're feelin'. Here are two sources for the D.E.A.'s position, which of course, come from cannabis sources who know what this means for the mushroom. One has an actual letter from the D.E.A. to the inquiring attorney way down at the bottom of the page. Read on either headline to read the coverage:DEA CONFIRMS PSYCHEDELIC MUSHROOM SPORES ARE LEGAL DEA Confirms That Psychedelic Mushroom Spores Are Federally Legal Prior To Germination (DEA letter at the bottom.) What is absolutely bizarre is we can find ZERO national news coverage other than these industry blogs. And we are good at means you are among the very few who knows about the milestone moment for mycelium and mushrooms and what an absolute gamechanger it is for Hypha Labs and their magical Micropearls. As this article was being prepared for release, breaking news from New Mexico warrants mention. The state's governor has signed a bill allowing for psilocybin use in the state. As indicated in this release from Hypha, this is a massive step forward to acceptance and a rapidly expanding market for Hypha Lab's revolutionary Micro Pearls device. More on Hypha here. We intend to cover Hypha Labs for the next couple months at minimum and to closely track their development and execution of their business model. If you see what we see, we suggest you add the ticker 'FUNI' to your watchlist and take a moment to review the Company's Investor Presentation at the following link: About The Emerging Markets Report:The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets. For more informative reports such as this, please sign up at Must Read OTC Markets/SEC policy on stock promotion and investor protection Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below. We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies. The Company's external Investor Relations firm, Integrity Media Inc, has contributed significantly to this report and holds or is owed six-million shares through a current or previous service agreement. EMC has been paid $50,000 by Hypha Labs on its own behalf for various marketing services including this report. EMC does not independently verify any of the content linked to this editorial. Please see our full disclaimer. For media inquiries, please contact Maggie Caraway at maggie@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
12-05-2025
- Business
- Associated Press
Emerging Markets Report: A Milestone for Mycelium
Underreported D.E.A. Letter and Policy Position Could be a Game Changer for Mushroom Enthusiasts An Emerging Markets Sponsored Commentary ORLANDO, Fla., May 12, 2025 (GLOBE NEWSWIRE) -- At the Emerging Market Report we are comprised of a team of veteran journalists, authors, former stock brokers, financial professionals, and unabashed opportunists who all come together to publish these tidy missives on our client profiles. We are constantly searching for impactful news that could be gamechangers for the Companies we cover. And we sure missed a big piece. So did just about everybody else. That big piece could be a major catalyst for Hypha Labs (OTCQB: FUNI) which makes the first at-home and commercial patent-pending mushroom ingredient maker of its kind. The elevator pitch is that Hypha Labs is to mushrooms as the clever Keurig was, is, to coffee. Massive potential disruptor in a massive market. Hypha's story is already a game changer as it is going to allow the soccer mom at home to make her preferred mushroom ingredient in a simple eight-day cycle. Pop in a cartridge, scan the bar code, wait eight days and enjoy the magic of the mushroom. Total privacy, no more growing 'shrooms in animal feces. But the mushroom industry is a decade or more behind the Emancipation of Cannabis. That cannabis revolution has almost completely come already with weed available most everywhere and a reasonable expectation that the government will change the arcane way it is classified/scheduled at the federal level. The cannabis movement started simply enough; some vocal folk argued the medicinal benefits AND the economic benefits to states that would listen and states started to go green. Once a few states implemented pro-Cannabis legislation they provided good working test market examples for other states to see that there wasn't a new filming of Reefer Madness on the streets and there were indeed many a cannabis driven dollar going into the state coffers that could be used for things like better schools and roads. I've buried the lead here but then again, it's been buried for a long, long time. Don't kill the messenger. Here's the buried bombshell: The Drug Enforcement Agency (DEA) appears to have taken a firm position that mycelium is ok to ship across state lines, although there are three states which currently don't allow mycelium to be shipped across state lines. Mycelium is the inactive root-like structure which later becomes a mushroom when it begins to fruit, which is what happens when it is fed nutrients. That's pretty good news if you're a company like Hypha Labs that will ship mycelium across eligible state lines once the retail roll-out of the Micropearls machine goes live. As described, Hypha sends you mycelium and based on your desires and a little A.I. you set your eight day harvest to whatever mushroom crop you're feelin'. Here are two sources for the D.E.A.'s position, which of course, come from cannabis sources who know what this means for the mushroom. One has an actual letter from the D.E.A. to the inquiring attorney way down at the bottom of the page. Read that. Click on either headline to read the coverage: DEA CONFIRMS PSYCHEDELIC MUSHROOM SPORES ARE LEGAL DEA Confirms That Psychedelic Mushroom Spores Are Federally Legal Prior To Germination (DEA letter at the bottom.) What is absolutely bizarre is we can find ZERO national news coverage other than these industry blogs. And we are good at Googling. This means you are among the very few who knows about the milestone moment for mycelium and mushrooms and what an absolute gamechanger it is for Hypha Labs and their magical Micropearls. Editor's Note:As this article was being prepared for release, breaking news from New Mexico warrants mention. The state's governor has signed a bill allowing for psilocybin use in the state. As indicatedin this release from Hypha, this is a massive step forward to acceptance and a rapidly expanding market for Hypha Lab's revolutionary Micro Pearls device. More on Hypha here. We intend to cover Hypha Labs for the next couple months at minimum and to closely track their development and execution of their business model. If you see what we see, we suggest you add the ticker 'FUNI' to your watchlist and take a moment to review the Company's Investor Presentation at the following link: About The Emerging Markets Report: The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets. For more informative reports such as this, please sign up at Must Read OTC Markets/SEC policy on stock promotion and investor protection Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below. We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies. The Company's external Investor Relations firm, Integrity Media Inc, has contributed significantly to this report and holds or is owed six-million shares through a current or previous service agreement. EMC has been paid $50,000 by Hypha Labs on its own behalf for various marketing services including this report. EMC does not independently verify any of the content linked to this editorial. Please see our full disclaimer. For media inquiries, please contact Maggie Caraway at [email protected]
Associated Press
09-04-2025
- Business
- Associated Press
New Mexico Governor Signs Bill Allowing for Psilocybin Use
'Medical Psilocybin Act' Provides Legal Access to Citizens for the First Time LAS VEGAS, NV / ACCESS Newswire / April 9, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce that New Mexico governor Michelle Lujan signed SB 219, the Medical Psilocybin Act, which will establish the third state-legal psilocybin access system in the United States. The Medical Psilocybin Act will provide patients with specific qualifying conditions to obtain the psychedelic and to use it under the guidance of a licensed healthcare provider. 'Today is another watershed event for functional mushrooms and the growing acceptance of their practical use in an array of applications,' stated Hypha Labs Chief Executive Officer, Stone Douglass. 'And it is long overdue.' 'As we embark on our journey to create the first device of its kind which will truly democratize mushroom ingredient production by allowing an individual to produce their desired 'crops' in predictable eight day cycles from the privacy and comfort of home, transformative events like this both affirm our mission and expand our market.' 'We believe as the legislative dominoes fall that other jurisdictions will see the successes in places like New Mexico as a template for their own jurisdictions,' added Douglass. 'We are at a tipping point.' About Hypha Labs, Inc. The company has developed revolutionary, cutting-edge technology focused on new methods of producing the active ingredients found in a wide array of functional mushrooms using its patent-pending mushroom accelerators. The Company is positioning itself to play an important role in the burgeoning Functional Mushroom industry in addition to being a disruptive force in future and emerging mushroom opportunities. Visit us at SAFE HARBOR FORWARD-LOOKING STATEMENTS: This press release may contain forward-looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as 'estimate,' 'project,' 'predict,' 'will,' 'would,' 'should,' 'could,' 'may,' 'might,' 'anticipate,' 'plan,' 'intend,' 'believe,' 'expect,' 'aim,' 'goal,' 'target,' 'objective,' 'likely' or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise. From time to time, the Company may post new and material information on its website or through its social media profiles at the links below: Integrity MediaInc.
